Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Brachytherapy in the Treatment of Prostate Cancer (CROSBI ID 129137)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Fröbe, Ana ; Jakšić, Blanka ; Bokulić, Tomislav ; Bolanča, Ante ; Budanec Mirjana ; Kusić, Zvonko Brachytherapy in the Treatment of Prostate Cancer // Acta clinica Croatica, 43 (2004), S1; 53-59

Podaci o odgovornosti

Fröbe, Ana ; Jakšić, Blanka ; Bokulić, Tomislav ; Bolanča, Ante ; Budanec Mirjana ; Kusić, Zvonko

engleski

Brachytherapy in the Treatment of Prostate Cancer

Brachytherapy for cancer of the prostate can be performed using either low dose rate (LDR) or high dose rate (HDR)techniques.The most widely udes LDR techniques are permanent seed implants, iodine-125 (I-125) or palladium-103(Pd-103).Once implanted in the prostate, the seed remain there.Early reports indicate that HDR monotherapy for early prostate cancer is feasible.Adoption of HDR prostate brachytherapy has been slower than LDR seed implants.Longer follow up and comparative studies are needed to ascertain its position among various definitive irradiation schemes for prostate cancer.

Brachytherapy ; Prostatic neoplasms-radiotherapy ; Prostatic neoplasms-pathology ; Prostatic neoplasms-surgery

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

43 (S1)

2004.

53-59

objavljeno

0353-9466

1333-9451

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost